---
schema_version: "secwatch.filing_event.v1"
accession: "0001854270-24-000091"
form_type: "8-K"
ticker: "SNTI"
cik: "0001854270"
company_name: "Senti Biosciences, Inc."
filed_at: "2024-07-16T23:59:59+00:00"
generated_at: "2026-05-31T20:34:12.726334+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Senti Biosciences amends ChEF purchase agreement to allow intraday VWAP share sales under $50M facility

## Summary
- Entered amended ChEF purchase agreement with Chardan Capital Markets for existing $50M equity facility.
- Amendment permits intraday volume-weighted average price (VWAP) purchases of common stock.
- The change gives the company flexibility to sell shares more frequently under the facility.
- Shares sold under the agreement are restricted securities and resale registered under Registration Rights Agreement.
- The Agreement amends and restates the original August 31, 2022 ChEF Purchase Agreement.

## SEC filing metadata
- accession: 0001854270-24-000091
- form_type: 8-K
- ticker: SNTI
- cik: 0001854270
- company_name: Senti Biosciences, Inc.
- filed_at: 2024-07-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1854270/000185427024000091/0001854270-24-000091-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1854270/000185427024000091/snti-20240716.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001854270-24-000091
- JSON: https://secwatch.observer/filing/0001854270-24-000091.json
- Plain text: https://secwatch.observer/filing/0001854270-24-000091.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.